Literature DB >> 10982070

The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey.

F Termorshuizen1, J W Dorigo-Zetsma, H E de Melker, S van den Hof, M A Conyn-Van Spaendonck.   

Abstract

The prevalence of antibodies to hepatitis A virus was assessed in a Dutch nationwide sample (n = 7367). A questionnaire was used to study the association with various sociodemographic characteristics. Overall, 33.8% (95% CI 31.6-36%) of the population had hepatitis A antibodies. The seroprevalence was less than 10% in people under 35; it increased from 25% at 35 years to 85% at 79 years. For those 15-49 years of age, Turks (90.9%) and Moroccans (95.8%) had greater seroprevalence than autochthonous Dutch (20.2%) and other Western people (25%). Low or middle socio-economic status, as indicated by the highest educational level achieved, was associated with greater seroprevalence, independently of age and reported immunization (OR 2.11 and 1.45; 95% CI 1.67-2.67 and 1.11-1.89, respectively). These data suggest autochthonous Dutch and other Westerners born after World War II were exposed to hepatitis A during childhood less frequently than older birth cohorts. Thus, more susceptibility is likely in the coming decades. Since this means a greater risk of outbreaks in future years, and since morbidity and mortality are more frequent in older persons, studying the cost effectiveness of selective and general vaccination might be worthwhile.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982070      PMCID: PMC2810932          DOI: 10.1017/s0950268899003842

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

1.  Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.

Authors:  Filippo Ansaldi; Bianca Bruzzone; Maria Cristina Rota; Antonino Bella; Marta Ciofi degli Atti; Paolo Durando; Roberto Gasparini; Giancarlo Icardi
Journal:  Eur J Epidemiol       Date:  2007-11-03       Impact factor: 8.082

2.  Illness-death model: statistical perspective and differential equations.

Authors:  Ralph Brinks; Annika Hoyer
Journal:  Lifetime Data Anal       Date:  2018-01-27       Impact factor: 1.588

3.  A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium.

Authors:  Sophie Quoilin; Veronik Hutse; Hans Vandenberghe; Françoise Claeys; Els Verhaegen; Liesbet De Cock; Frank Van Loock; Geert Top; Pierre Van Damme; Robert Vranckx; Herman Van Oyen
Journal:  Eur J Epidemiol       Date:  2007-03-14       Impact factor: 8.082

4.  Socioeconomic correlates of antibody levels to enteric pathogens among Israeli adolescents.

Authors:  T Hasin; R Dagan; G Boutboul; E Derazne; O Atias; D Cohen
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

5.  Epidemiology and economic burden of viral hepatitis: an observational population based study.

Authors:  D T Steinke; T L Weston; A D Morris; T M MacDonald; J F Dillon
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

6.  Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.

Authors:  Ana Martínez; Sonia Broner; M Rosa Sala; Sandra Manzanares-Laya; Pere Godoy; Caritat Planas; Sofia Minguell; Nuria Torner; Mireia Jané; Angela Domínguez; The Working Group For The Study Of The Immune Status In Health Care; For The Study Of Hepatitis A In Catalonia
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

7.  Hepatitis A virus immunity and seroconversion among contacts of acute hepatitis A patients in Amsterdam, 1996-2000: an evaluation of current prevention policy.

Authors:  Gerard J B Sonder; Jim E van Steenbergen; Lian P M J Bovee; Paul G H Peerbooms; Roel A Coutinho; Anneke van den Hoek
Journal:  Am J Public Health       Date:  2004-09       Impact factor: 9.308

Review 8.  Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran.

Authors:  Ziba Farajzadegan; Shervin Ghaffari Hoseini; Roya Kelishadi; Fahimeh Jamshidi; Zari Nokhodian; Rasool Noori; Parisa Mirmoghtadaee; Silva Hovsepian; Seyyed-Nassereddin Mostafavi
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852

9.  Effects of an ageing population and the replacement of immune birth cohorts on the burden of hepatitis A in the Netherlands.

Authors:  Scott A McDonald; Marie-Josée J Mangen; Anita Suijkerbuijk; Edoardo Colzani; Mirjam E E Kretzschmar
Journal:  BMC Infect Dis       Date:  2013-03-05       Impact factor: 3.090

10.  Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study.

Authors:  Angela Domínguez; Miquel Bruguera; Pere Plans; Jordi Espuñes; Josep Costa; Antoni Plasencia; Lluis Salleras
Journal:  BMC Infect Dis       Date:  2007-07-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.